Prof. Yinglu Guo, MD

First Affiliated Hospital of Peking University, Academician of China Academy of Engineering, Dean of School of Urology Surgeon Training of Peking University, Beijing, China

Prof. Yinglu Guo, MD, is an academician of Chinese Academy of Engineering, academic leader of Urology and Andrology. Prof. Guo graduated from Beijing Medical College in 1956 and received his M.D. of Urology in 1963. Currently, Prof. Guo is the honorary president of Peking University First Hospital and honorary director of Institute of Urology, Peking University; Dean of Peking University Urologist Training College and Andrology Center of Peking University First Hospital; Dean of National Urological, male reproductive Cancer Research Center and Ministry of Health Urological, male reproductive Cancer Medical Center; President of Division of Urologist, Chinese Medical Doctor Association.

Prof. Guo has edited 32 monographs including ‘Kidney Transplantation’, ‘Endourology’ and published more than 500 articles. Prof. Guo was involved in the formation of the first institute of urology in China, the formation of Endourology and ESWL Study Group, the formation of Andrology Society of Chinese Medical Association, the formation of Division of Urologist, Chinese Medical Doctor Association, the formation of Peking University Urologist Training College, the formation of Andrology Center of Peking University First Hospital and the formation of National Urological, male reproductive Cancer Research Center and Ministry of Health Urological, male reproductive Cancer Medical Center.

Prof. Guo started the ‘Talent Project’ and ‘Jiang-cai Project’ on Urology, which have trained a large number of professional urologists with extensive knowledge, working ability, good quality and creativity. Prof. Guo has made an outstanding contribution to the development of Chinese Urology!

Prof. Tom F. Lue, MD, ScD (Hon), FACS

Department of Urology, University of California, San Francisco, CA, USA

Dr. Tom F. Lue is Professor and Vice-Chair of Urology at UCSF. He also is Director of the Knuppe Molecular Urology Laboratory, a recipient of NIH MERIT Award for his translational research in penile physiology and erectile dysfunction. His team discovered the anatomical mechanism of venous compression during penile erection, published the first article implicating TGF beta in the formation of Peyronie’s plaque, and developed the animal models for the study of Peyronie’s disease and stress urinary incontinence. His clinical research "firsts" include authorship of the New England Journal of Medicine paper describing the landmark clinical trial introducing Sildenafil (Viagra®) for erectile dysfunction, and the development of four diagnostic tests for erectile dysfunction: the penile injection and stimulation test, the duplex ultrasound test for penile arterial flow, pharmacologic cavernosography for venous leakage, and the use of duplex ultrasound to diagnose priapism. He also developed seven new surgical procedures for Peyronie’s disease, priapism and erectile dysfunction. He has been the recipient of the American Urological Association's Gold Cystoscope Award and the American Foundation of Urological diseases’ Most Innovative Researcher Award. He Chaired the International Consultation on Sexual Medicine held in Paris in July 2003 serving as lead author of its published proceedings. He was the honorary president of the same meeting in Paris in July, 2009.

Dr. Lue's current basic science research projects involve the development of animal models for research in erectile dysfunction due to hormone deficiency, cavernous nerve injury, diabetes mellitus and hyperlipidemia. Regarding Peyronie’s disease, he is currently testing the hypothesis that prolonged inflammation/autoimmune reaction is involved in the pathogenesis of Peyronie’s disease. His lab also has 10 years of experience in basic cell biology research of mesenchymal stem cells [MSC]. His lab is one of the first to show evidence that MSCs are vascular stem cells existing in various tissues and paracrine effect may be involved in the action of implanted MSC in addition to cellular differentiation. Using animal models, Dr. Lue also is exploring the feasibility of using adipose tissue derived adult stem cells as a source of stem cells for the treatment of stress urinary incontinence, neurogenic impotence and functional recovery after spinal cord injury. The application of MSC in erectile dysfunction is scheduled for clinical trial soon.

Besides being listed in The Best Doctors in America and America’s Top Doctors for many years, he was named one of the 8 top doctors for men by Men’s Health Magazine in 2003. He has published more than 360 peer reviewed articles and more than 100 book chapters. His research team has trained more than 70 postgraduate doctors and most of them are continuing research career in academic institutions in many countries.